Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost savings ...

The dose of the first- or second-generation β blocker that the patient is receiving is an important consideration for the switching regimen chosen. The major factors to be kept in mind when ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans ...

A new study by researchers at Karolinska Institutet and Södersjukhuset shows that advanced ultrasound imaging analyses cannot ...